grepcent public filings, reorganized for comparison

GENWORTH FINANCIAL INC (GNW) FY 2023 MD&A

Verbatim Item 7 Management's Discussion and Analysis from GENWORTH FINANCIAL INC's 10-K for fiscal year 2023. Filing date: 2024-02-29. Report date: 2023-12-31. Accession: 0001193125-24-051772.

This page reproduces the company's own Item 7 MD&A text from the linked SEC filing. It is filer text, not grepcent analysis, scoring, or investment advice.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high.

Company profile: GNW · All MD&A years: index · Previous year: FY 2022 · Next year: FY 2024

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”

Item 7 of our Annual Report on Form
10-K
generally discusses

year-to-year

comparisons between the years ended December 31, 2023 and 2022. In addition, with the exception of our Enact segment, this Form
10-K
also includes discussions of information related to 2021 and

year-to-year

comparisons between 2022 and 2021, which have been
re-presented
to reflect the adoption of LDTI and the change in our operating segments. Detailed comparative discussions between 2022 and 2021 for our Enact segment, which was not impacted by the new accounting guidance or change in operating segments, can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” in our Annual Report on Form
10-K
for the year ended December 31, 2022.

Overview

Our business

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage
in-force
blocks of life insurance and annuity products which are no longer sold. We report our business results through three operating business segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three operating segments, we report certain of our results of operations in Corporate and Other.

Our financial information

The financial information in this Annual Report on Form
10-K
has been derived from our consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

Column 1Column 2Column 3Column 4
Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.
Column 1Column 2Column 3Column 4
Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees.

69

Table of Contents

Our expenses consist primarily of the following:

Column 1Column 2Column 3Column 4
Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense and other reserve activity related to current claims, as well as future policy benefits on insurance and investment products for long-term care insurance, life insurance, fixed and variable annuities, and claim costs incurred related to mortgage insurance products.
Column 1Column 2Column 3Column 4
Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual versus expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts.
Column 1Column 2Column 3Column 4
Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments associated with our market risk benefits.
Column 1Column 2Column 3Column 4
Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.
Column 1Column 2Column 3Column 4
Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate corporate expenses to each of our operating segments using various methodologies.
Column 1Column 2Column 3Column 4
Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of acquisition costs that are capitalized, present value of future profits and capitalized software.
Column 1Column 2Column 3Column 4
Interest expense. Interest expense represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings, and certain reinsurance arrangements being accounted for as deposits.
Column 1Column 2Column 3Column 4
Provision (benefit) for income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other.

The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers.

Column 1Column 2Column 3Column 4
Net income from continuing operations attributable to noncontrolling interests. Net income from continuing operations attributable to noncontrolling interests represents the portion of income from continuing operations in a subsidiary attributable to third parties.

70

Table of Contents

Consolidated Results of Operations

The following table sets forth the consolidated results of operations for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$3,636$3,680$3,406$(44)(1)%$2748%
Net investment income3,1833,1463,370371%(224)(7)%
Net investment gains (losses)23(2)32225NM(1)(324)(101)%
Policy fees and other income646671724(25)(4)%(53)(7)%
Total revenues7,4887,4957,822(7)%(327)(4)%
Benefits and expenses:
Benefits and other changes in policy reserves4,7834,3034,57548011%(272)(6)%
Liability remeasurement (gains) losses587(290)242877NM(1)(532)NM(1)
Changes in fair value of market risk benefits and associated hedges(12)(104)(160)9288%5635%
Interest credited503504511(1)%(7)(1)%
Acquisition and operating expenses, net of deferrals9421,285998(343)(27)%28729%
Amortization of deferred acquisition costs and intangibles264326384(62)(19)%(58)(15)%
Interest expense1181061601211%(54)(34)%
Total benefits and expenses7,1856,1306,7101,05517%(580)(9)%
Income from continuing operations before income taxes3031,3651,112(1,062)(78)%25323%
Provision for income taxes104319248(215)(67)%7129%
Income from continuing operations1991,046864(847)(81)%18221%
Income from discontinued operations, net of taxes27%(27)(100)%
Net income1991,046891(847)(81)%15517%
Less: net income from continuing operations attributable to noncontrolling interests12313033(7)(5)%97NM(1)
Less: net income from discontinued operations attributable to noncontrolling interests8%(8)(100)%
Net income available to Genworth Financial, Inc.’s common stockholders$76$916$850$(840)(92)%$668%
Net income available to Genworth Financial, Inc.’s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders$76$916$831$(840)(92)%$8510%
Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders19%(19)(100)%
Net income available to Genworth Financial, Inc.’s common stockholders$76$916$850$(840)(92)%$668%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

71

Table of Contents

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of
non-GAAP
measures

Reconciliation of net income (loss) to adjusted operating income (loss)

Management uses
non-GAAP
financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share” to evaluate performance and allocate resources. Adjusted operating income (loss) per share is derived from adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual
non-operating
items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual
non-operating
items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance.

While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss), among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.

72

Table of Contents

The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31:

(Amounts in millions)202320222021
Net income available to Genworth Financial, Inc.’s common stockholders$76$916$850
Add: net income from continuing operations attributable to noncontrolling interests12313033
Add: net income from discontinued operations attributable to noncontrolling interests8
Net income1991,046891
Less: income from discontinued operations, net of taxes27
Income from continuing operations1991,046864
Less: net income from continuing operations attributable to noncontrolling interests12313033
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders76916831
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)(25)2(322)
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2)(22)(142)(210)
(Gains) losses on early extinguishment of debt (3)(2)645
Expenses related to restructuring4234
Pension plan termination costs8
Taxes on adjustments102696
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$41$818$474
Column 1Column 2
(1)For the year ended December 31, 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million.
Column 1Column 2
(2)Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million for the years ended December 31, 2023, 2022 and 2021, respectively.
Column 1Column 2
(3)See note 17 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on (gains) losses on early extinguishment of debt during 2023 and 2022. During 2021, we paid pre-tax make-whole premiums of $26 million and incurred pre-tax losses of $19 million in connection with the early redemption and repurchase of certain of Genworth Holdings’ senior notes.

Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented.

73

Table of Contents

Earnings per share

The following table provides basic and diluted earnings per common share for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions, except per share amounts)2023202220212023 vs. 20222022 vs. 2021
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.16$1.82$1.64$(1.66)(91)%$0.1811%
Diluted$0.16$1.79$1.61$(1.63)(91)%$0.1811%
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.16$1.82$1.68$(1.66)(91)%$0.148%
Diluted$0.16$1.79$1.65$(1.63)(91)%$0.148%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.09$1.62$0.93$(1.53)(94)%$0.6974%
Diluted$0.09$1.60$0.92$(1.51)(94)%$0.6874%
Weighted-average common shares outstanding:
Basic468.8504.4506.9
Diluted474.9510.9514.7

Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards.

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Enact segment$552$578$520$(26)(4)%$5811%
Long-Term Care Insurance segment(242)320126(562)(176)%194154%
Life and Annuities segment:
Life insurance(275)(111)(201)(164)(148)%9045%
Fixed annuities506283(12)(19)%(21)(25)%
Variable annuities3721221676%(1)(5)%
Life and Annuities segment(188)(28)(96)(160)NM(1)6871%
Corporate and Other(81)(52)(76)(29)(56)%2432%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$41$818$474$(777)(95)%$34473%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

74

Table of Contents

Executive Summary of Consolidated Financial Results

Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated.
After-tax
amounts assume a tax rate of 21%.

For a discussion of selected financial information and detailed descriptions of operating performance measures, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

2023 compared to 2022

Column 1Column 2Column 3Column 4
Net income in 2023 and 2022 was $76 million and $916 million, respectively, and adjusted operating income was $41 million and $818 million, respectively. Adjusted operating income (loss) highlights were as follows:
Column 1Column 2Column 3Column 4
Enact segment
Column 1Column 2Column 3Column 4
Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower operating costs in 2023.
Column 1Column 2Column 3Column 4
Long-Term Care Insurance segment
Column 1Column 2Column 3Column 4
The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022.
Column 1Column 2Column 3Column 4
The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to a legal settlement.
Column 1Column 2Column 3Column 4
We also experienced higher operating costs and lower premiums in 2023.
Column 1Column 2Column 3Column 4
Life and Annuities segment
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023.
Column 1Column 2Column 3Column 4
These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 that did not recur.
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience in 2023.
Column 1Column 2Column 3Column 4
Variable annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 2023.

75

Table of Contents

Column 1Column 2Column 3Column 4
Corporate and Other
Column 1Column 2Column 3Column 4
The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023.

2022 compared to 2021

Column 1Column 2Column 3Column 4
Net income in 2022 and 2021 was $916 million and $850 million, respectively, and adjusted operating income was $818 million and $474 million, respectively. Adjusted operating income (loss) highlights were as follows:
Column 1Column 2Column 3Column 4
Enact segment
Column 1Column 2Column 3Column 4
Adjusted operating income increased primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the economic environment.
Column 1Column 2Column 3Column 4
This improvement was partially offset by the minority initial public offering of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%.
Column 1Column 2Column 3Column 4
The improvement was also partially offset by lower premiums in 2022.
Column 1Column 2Column 3Column 4
Long-Term Care Insurance segment
Column 1Column 2Column 3Column 4
Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of a legal settlement, partially offset by lower net investment income in 2022.
Column 1Column 2Column 3Column 4
Life and Annuities segment
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality.
Column 1Column 2Column 3Column 4
The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products.
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022.
Column 1Column 2Column 3Column 4
Corporate and Other
Column 1Column 2Column 3Column 4
The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

76

Table of Contents

Significant Developments and Strategic Highlights

Enact segment

Column 1Column 2Column 3Column 4
Mortgage insurance portfolio. Enact’s primary persistency rate was 85% during 2023 compared to 80% during 2022. Elevated persistency continued to offset a decline in new insurance written, contributing to insurance in-force growth in 2023. New insurance written decreased 20% during 2023 compared to 2022 mostly from a decline in originations due to elevated interest rates.
Column 1Column 2Column 3Column 4
Loss performance. Enact recorded favorable pre-tax reserve releases of $241 million in 2023 primarily related to favorable cure performance on 2022 and prior delinquencies, including those related to COVID-19. New primary delinquencies in 2023 increased compared to 2022 largely due to the aging of large, new books of business.
Column 1Column 2Column 3Column 4
Capital. Enact’s PMIERs sufficiency ratio was 161% or $1,887 million above the PMIERs requirements as of December 31, 2023.
Column 1Column 2Column 3Column 4
Capital returns. Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023.

Long-Term Care Insurance segment

Column 1Column 2Column 3Column 4
In-force rate actions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan from 2012 through 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements as described in “Results of Operations and Selected Financial and Operating Performance Measures by Segment.” This estimated cumulative economic benefit reflects progress of approximately 84% toward our latest estimate of approximately $33.3 billion total net present value of premium increases and benefit reductions contemplated in our multi-year in-force rate action plan, which also takes into account our current updated assumptions. As a result, based on current assumptions, the remaining estimated amount to be achieved through future rate action approvals under our in-force rate action plan was reduced by $1.5 billion in 2023 to approximately $5.3 billion.
Column 1Column 2Column 3Column 4
Claims. We expect higher paid claims in our long-term care insurance business as our blocks age with peak claim years over a decade away. Paid claims on newer products continue to increase as policyholders approach peak claim age, while claims on our older products decline as those policyholders are past peak claim age. We also expect overall claim costs to continue to increase as the approximately 625,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 77 and 74, respectively, reach their peak claim years, which are over age 85.
Column 1Column 2Column 3Column 4
Actual to expected experience. Unfavorable pre-tax actual versus expected experience of $269 million in 2023 was primarily driven by higher claims and unfavorable timing impacts related to a legal settlement.
Column 1Column 2Column 3Column 4
Annual assumption review. As part of our annual review of assumptions in the fourth quarter of 2023, our long-term care insurance business had unfavorable pre-tax impacts of $61 million from cash flow assumption updates. We made unfavorable updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse rates, partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our long-term care insurance cash flow assumptions. Assumption updates also included changes for future in-force rate action approvals and benefit reductions based on recent favorable experience and reflect a recent legal settlement that primarily impacted uncapped cohorts.

Life and Annuities segment

Column 1Column 2Column 3Column 4
As part of our annual review of assumptions in the fourth quarter of 2023, our life insurance business had unfavorable pre-tax impacts of $226 million from cash flow assumption updates. We made

77

Table of Contents

Column 1Column 2
unfavorable cash flow assumption updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19, similar to long-term care insurance. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our life insurance cash flow assumptions.

Capital of U.S. life insurance subsidiaries

Column 1Column 2Column 3Column 4
As of December 31, 2023 and 2022, the consolidated RBC ratio on a company action level basis of our U.S. domiciled life insurance subsidiaries was approximately 303% and 291%, respectively. The increase was primarily driven by earnings in our annuity products, including a net benefit to variable annuities from the impact of equity market and interest rate performance, as well as a net favorable impact from assumption updates primarily in our life insurance products in 2023.

Genworth Financial share repurchase program

Column 1Column 2Column 3Column 4
Genworth Financial executed $295 million in share repurchases, excluding excise taxes and other associated costs, during 2023.

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Management’s discussion and analysis by segment contains selected operating performance measures including “sales” and “insurance
in-force”
or “risk
in-force”
which are commonly used in the insurance industry as measures of operating performance.

Management regularly monitors and reports sales metrics as a measure of volume of new business generated in a period. Sales refer to new insurance written for mortgage insurance products included in our Enact segment. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of insurance policies during a specified period, rather than a measure of revenues or profitability during that period. Management also regularly monitors and reports insurance
in-force
and risk
in-force
for our Enact segment. Insurance
in-force
is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk
in-force
is based on the coverage percentage applied to the estimated current outstanding loan balance. We consider insurance
in-force
and risk
in-force
to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period. These metrics are presented on a direct basis and exclude reinsurance.

Management also regularly monitors and reports a loss ratio for our Enact segment. The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums, and we consider it to be a measure of underwriting performance and helps to enhance the understanding of the operating performance of our Enact segment.

Management regularly monitors and reports on
in-force
rate actions, including state filing approvals; impacted
in-force
premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year
in-force
rate action plan on a net present value basis, discounted at our investment portfolio yield. This is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on individual and group long-term care insurance policies and reserve reductions related to legal settlements less

78

Table of Contents

cash payments made to policyholders who elect certain reduced benefit options in connection with the legal settlements, referred to as settlement payments. We monitor these selected operating performance measures for
in-force
rate actions to track our progress on ensuring the continued self-sustainability of our long-term care insurance business over time. We consider these
in-force
rate actions metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment.

These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources.

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

Macroeconomic environment

Mortgage origination activity remained slow throughout 2023 in response to elevated mortgage rates and sustained low housing supply. Housing affordability continued to deteriorate due to high interest rates and elevated home prices, only marginally offset by rising median family income, according to the National Association of Realtors Housing Affordability Index. National home prices rose modestly throughout 2023, according to the FHFA Monthly Purchase-Only House Price Index.

The unemployment rate increased to 3.7% in December 2023, compared to 3.5% in December 2022. As of December 31, 2023, the number of unemployed Americans was approximately 6.3 million, and the number of long term unemployed over 26 weeks was approximately 1.2 million. Both metrics remain relatively in line with
pre-pandemic
levels in February 2020.

Forbearance and loss mitigation programs

For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac),
COVID-19
forbearance allowed borrowers impacted by
COVID-19
to temporarily suspend mortgage payments up to 18 months subject to certain limits. However, the Biden Administration ended the national emergency for
COVID-19
in April 2023, and as a result, the deadline for requesting a
COVID-19
related forbearance under the CARES Act ended in August 2023. The GSEs retired their
COVID-19
servicing-related policies including with respect to forbearance effective November 1, 2023 and reverted to standard forbearance policies as a loss mitigation option for borrowers that meet general hardship and program guidelines.

In March 2023, the GSEs announced new loss mitigation programs that allow
six-month
payment deferrals for borrowers facing financial hardship and encouraged servicers to start evaluating borrowers for these programs as early as July 1, 2023 but no later than October 1, 2023. Even though most foreclosure moratoriums expired at the end of 2021, federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend foreclosure timelines, which could negatively impact the severity of loss on loans that go to claim.

79

Table of Contents

Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2023, approximately 1.2% or 11,536 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 31% were reported as delinquent.

The full impact of
COVID-19
and its associated economic effects on Enact’s future business results are difficult to predict. Given the maximum length of forbearance plans, the resolution of a delinquency in a plan still may not be known for several quarters or longer. Enact continues to monitor regulatory and government actions and the resolution of forbearance delinquencies. While the associated risks have moderated and delinquencies related to
COVID-19
have declined, it is possible that ancillary economic effects of
COVID-19
could have an adverse impact on Enact’s future results of operations and financial condition.

Regulatory developments

Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products.

On October 24, 2022, the FHFA announced targeted changes to the GSEs’ guarantee fee pricing by eliminating upfront fees for certain first-time home buyers with income at or below area median income and for certain GSE affordable mortgage products, while implementing targeted increases to the upfront fees for most
cash-out
refinance loans. The fee reductions went into effect in the fourth quarter of 2022 while the new fees on
cash-out
refinance loans began February 1, 2023. Enact has seen a limited impact from these price changes on the private mortgage insurance market.

The FHFA also announced in October 2022 its validation and approval of certain credit score models for use by the GSEs and changed the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores requires lenders to deliver both credit scores for each loan sold to the GSEs. The FHFA has announced preliminary implementation expectations, but this is expected to be a multiple year process that will require system and process updates.

In January 2023, the FHFA announced additional updates to its upfront fee structure and pricing matrix. The changes marked the third iteration of the FHFA’s ongoing pricing review since early 2022 and impact purchase and rate-term refinance loans. Pricing grids are now broken out by loan purpose and are recalibrated to new credit score and

loan-to-value

ratio categories, along with associated loan attributes. The new pricing matrix initially included new upfront fees for loans with

debt-to-income

ratios greater than 40% but those fees were rescinded prior to implementation. The remaining changes became effective May 1, 2023.

In February 2023, the Department of Housing and Urban Development announced a 30 basis point reduction of the annual insurance premium charged to borrowers with
FHA-insured
mortgages in order to reduce the cost of borrowing for eligible lower and middle class homebuyers. This price reduction, which went into effect on March 20, 2023, is expected to have a negative impact on the U.S. private mortgage insurance market but will be partially offset by the effects of the recent FHFA pricing changes referenced above. Enact does not believe this net impact has been or will be material.

Competitive environment

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to

80

Table of Contents

manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite enabling it to write new business at returns it views as attractive.

Mortgage insurance portfolio

New insurance written of $53.1 billion in 2023 decreased 20% compared to 2022 mostly from a smaller estimated private mortgage insurance market as originations were impacted by elevated interest rates. Enact’s primary persistency rate was 85% for the year ended December 31, 2023 compared to 80% for the year ended December 31, 2022. The increase in persistency was primarily driven by a decline in the percentage of
in-force
policies with mortgage rates above current mortgage rates and offset the decline in new insurance written in 2023, contributing to an increase in insurance
in-force
of $14.7 billion during 2023.

Net earned premiums increased in 2023 compared to 2022 primarily driven by insurance
in-force
growth, partially offset by the lapse of older, higher priced policies and lower single premium policy cancellations in 2023. The total number of delinquent loans has declined from the
COVID-19
peak in the second quarter of 2020 as borrowers continued to exit forbearance plans and new forbearances declined. During this time and consistent with prior years, servicers continued the practice of remitting premiums during the early stages of default, and Enact refunds the post-delinquent premiums to the insured party if the delinquent loan goes to claim. Enact records a liability and a reduction to net earned premiums for the post-delinquent premiums it expects to refund. The post-delinquent premium liability recorded since the beginning of
COVID-19
in the second quarter of 2020 through December 31, 2023 was not significant to the change in earned premiums for those periods.

Loss experience

Enact’s loss ratio was 3% for the year ended December 31, 2023, compared to (10)% for the year ended December 31, 2022. Enact recorded favorable reserve adjustments of $241 million in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to
COVID-19.
During the peak of
COVID-19,
Enact experienced elevated new delinquencies subject to forbearance plans, and those delinquencies have continued to cure at levels above Enact’s reserve expectations. In addition, cure performance on delinquencies from 2022 has not been negatively impacted by uncertainty in the economic environment to the extent initially expected. During 2022, Enact recorded net favorable reserve adjustments of $268 million primarily related to favorable cure performance on
COVID-19
delinquencies from 2020 and 2021, partially offset by reserve strengthening on certain 2022 delinquencies.

Borrowers who have experienced a financial hardship including, but not limited to, the loss of income due to the closing of a business or the loss of a job continue to take advantage of available loss mitigation options, including forbearance programs, payment deferral options and other modifications. Loss reserves recorded on these delinquencies require a high degree of estimation due to the level of uncertainty regarding whether delinquencies in forbearance will ultimately cure or result in claim payments, as well as the timing and severity of those payments. The severity of loss on loans that do go to claim may be negatively impacted by the extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

New primary delinquencies in 2023 increased compared to 2022 primarily due to the aging of large, new books of business. New primary delinquencies of 41,617 contributed $265 million of loss expense in 2023, while Enact incurred $171 million of losses from 35,996 new primary delinquencies in 2022. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and

81

Table of Contents

prospective economic conditions. Approximately 13% of Enact’s primary new delinquencies in 2023 were subject to a forbearance plan compared to 21% in 2022. Due to the declining number of new delinquencies in forbearance, Enact no longer differentiates the expected claim rates applied to new delinquencies in forbearance versus those not in forbearance.

Capital requirements

As of December 31, 2023, EMICO’s

risk-to-capital

ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 11.6:1, compared with a

risk-to-capital

ratio of 12.9:1 as of December 31, 2022. EMICO’s

risk-to-capital

ratio remains below the NCDOI’s maximum

risk-to-capital

ratio of 25:1. North Carolina’s calculation of

risk-to-capital

excludes the risk
in-force
for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing

risk-to-capital

ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. In addition, in September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions on Enact with respect to capital. In May 2021, in connection with their conditional approval of the then potential partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions were met. These conditions were met as of December 31, 2022, and Enact is no longer subject to the GSE Restrictions and the GSE Conditions.

As of December 31, 2023, Enact had estimated available assets of $5,006 million against $3,119 million net required assets under PMIERs compared to available assets of $5,206 million against $3,156 million net required assets as of December 31, 2022. The sufficiency ratio as of December 31, 2023 was 161% or $1,887 million above the PMIERs requirements, compared to 165% or $2,050 million above the published PMIERS requirements as of December 31, 2022. Enact’s PMIERs required assets as of December 31, 2023 and 2022 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain
non-performing
loans. The application of the 0.30 multiplier to all eligible delinquencies provided $73 million and $132 million of benefit to Enact’s PMIERs required assets as of December 31, 2023 and 2022, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier.

During 2023, Enact executed excess of loss reinsurance transactions that provide up to $428 million of reinsurance coverage on a portion of its new insurance written for the 2022 and 2023 book years. Enact also executed a quota share reinsurance agreement under which it cedes 16.125% of a portion of new insurance written in the 2023 book year. Enact’s third-party reinsurance transactions provided an aggregate of approximately $1,714 million and $1,578 million of PMIERs capital credit as of December 31, 2023 and 2022, respectively.

On January 3, 2024, Enact entered into a quota share reinsurance agreement under which it will cede approximately 21% of a portion of its new insurance written in the 2024 book year. On January 30, 2024, Enact executed an excess of loss reinsurance transaction which provides up to $255 million of reinsurance coverage on a portion of current and expected new insurance written for the 2024 book year, effective January 1, 2024. See note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on Enact’s reinsurance transactions.

Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.

82

Table of Contents

Capital returns and other transactions

In April 2023 and November 2023, EMICO completed distributions to Enact Holdings that support its ability to pay a quarterly dividend. Enact Holdings intends to use these proceeds and future EMICO distributions to fund the quarterly dividend as well as to bolster its financial flexibility and potentially return additional capital to shareholders. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition to Enact’s quarterly dividend program, in November 2022, Enact Holdings announced approval by its board of directors of a share repurchase program under which it could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023 comprised of $82 million of quarterly dividends, a special dividend of $92 million and $71 million of share repurchases.

In May 2023, EMICO contributed $250 million to Enact Re, which enabled Enact Re to participate in the assumption of excess of loss reinsurance relating to GSE credit risk transfer and to reinsure EMICO’s new and existing insurance in-force under quota share reinsurance agreements. EMICO contributed an additional $250 million to Enact Re in November 2023, which will support an increase to the ceding percentage of affiliate quota share agreements, along with assumed new insurance written and new business opportunities, including the continued execution of GSE credit risk transfer.

Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings, as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, including: supporting its existing policyholders; growing its mortgage insurance business; funding attractive new business opportunities; and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.

83

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 2022
Revenues:
Premiums$957$940$975$172%
Net investment income2081551415334%
Net investment gains (losses)(14)(2)(2)(12)NM(1)
Policy fees and other income224%
Total revenues1,1531,0951,118585%
Benefits and expenses:
Benefits and other changes in policy reserves27(94)125121129%
Acquisition and operating expenses, net of deferrals212227230(15)(7)%
Amortization of deferred acquisition costs and intangibles111215(1)(8)%
Interest expense525251%
Total benefits and expenses30219742110553%
Income from continuing operations before income taxes851898697(47)(5)%
Provision for income taxes186194148(8)(4)%
Income from continuing operations665704549(39)(6)%
Less: net income from continuing operations attributable to noncontrolling interests12313033(7)(5)%
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders542574516(32)(6)%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (2)122210NM(1)
Expenses related to restructuring33(3)(100)%
Taxes on adjustments(2)(1)(1)(1)(100)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$552$578$520$(26)(4)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million.

2023 compared to 2022

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower operating costs in 2023.

Revenues

Premiums increased mostly from higher insurance
in-force,
partially offset by the lapse of older, higher priced policies, lower single premium policy cancellations and higher ceded premiums in 2023.

Net investment income increased primarily from higher investment yields and higher average invested assets in 2023.

84

Table of Contents

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023. Enact released $241 million of reserves in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to
COVID-19,
compared to net favorable reserve adjustments of $268 million in 2022.

Acquisition and operating expenses, net of deferrals, decreased primarily attributable to lower operating costs in 2023.

Provision for income taxes.

The effective tax rate was 21.8% and 21.6% for the years ended December 31, 2023 and 2022, respectively, consistent with the U.S. corporate federal income tax rate.

Enact selected operating performance measures

The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 2022
Primary insurance in-force$262,937$248,262$226,514$14,6756%
Risk in-force:
Primary$67,529$62,791$56,881$4,7388%
Pool6979105(10)(13)%
Total risk in-force$67,598$62,870$56,986$4,7288%
New insurance written$53,081$66,485$97,004$(13,404)(20)%

2023 compared to 2022

Primary insurance
in-force
and risk
in-force

Primary insurance
in-force
increased largely from new insurance written. In addition, lower lapses and cancellations drove higher primary persistency, largely as a result of suppressed refinancing activity due to a decline in the percentage of
in-force
policies with mortgage rates above current mortgage rates. Total risk
in-force
increased largely from higher primary insurance
in-force.

New insurance written

New insurance written decreased primarily due to a smaller estimated private mortgage insurance market in 2023 as both refinancing and purchase originations were impacted by elevated mortgage rates.

Loss and expense ratios

The following table sets forth the loss and expense ratios for Enact for the dates indicated:

Years ended December 31,Increase (decrease)
2023202220212023 vs. 2022
Loss ratio3%(10)%13%13%
Expense ratio23%25%25%(2)%

85

Table of Contents

The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles.

2023 compared to 2022

The loss ratio increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023, as discussed above.

The expense ratio decreased primarily attributable to lower operating costs in 2023.

86

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:

(Amounts in millions)202320222021
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above$44,955$39,509$35,455
90.01% to 95.00%109,227103,61895,149
85.01% to 90.00%77,88772,13264,549
85.00% and below30,86833,00331,361
Total$262,937$248,262$226,514
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above$12,878$11,136$9,907
90.01% to 95.00%31,78130,07927,608
85.01% to 90.00%19,16317,62115,644
85.00% and below3,7073,9553,722
Total$67,529$62,791$56,881
Primary insurance in-force by credit quality at origination:
Over 760$110,635$102,467$89,982
740—75943,05340,09735,874
720—73937,02034,91631,730
700—71929,76628,86727,359
680—69921,83521,55421,270
660—679(1)11,35710,92610,549
640—6596,1376,0956,124
620—6392,5042,6302,783
620630710843
Total$262,937$248,262$226,514
Primary risk in-force by credit quality at origination:
Over 760$28,363$25,807$22,489
740—75911,09610,1549,009
720—7399,6218,9318,055
700—7197,6237,3176,907
680—6995,5575,4285,334
660—679(1)2,9082,7672,638
640—6591,5651,5401,530
620—639635665702
620161182217
Total$67,529$62,791$56,881
Column 1Column 2
(1)Loans with unknown FICO scores are included in the 660-679 category.

The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance
in-force
was 744 as of December 31, 2023.

Delinquent loans and claims

Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an

87

Table of Contents

amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:

202320222021
Primary insurance:
Insured loans in-force974,516960,306937,350
Delinquent loans20,43219,94324,820
Percentage of delinquent loans (delinquency rate)2.10%2.08%2.65%

The delinquency rate as of December 31, 2023 increased compared to December 31, 2022 primarily from an increase in total delinquencies mostly driven by new delinquencies outpacing cures and paid claims. The delinquency rate as of December 31, 2023 decreased compared to December 31, 2021 primarily from a decline in total delinquencies as cures outpaced new delinquencies.

The following tables set forth primary delinquencies, direct primary case reserves and risk
in-force
by aged missed payment status in Enact’s loan portfolio as of December 31:

2023
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less10,166$88$62914%
4 – 11 payments6,93420546944%
12 payments or more3,33218420092%
Total20,432$477$1,29837%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
2022
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less8,920$69$50914%
4 – 11 payments6,46616639043%
12 payments or more4,55724424898%
Total19,943$479$1,14742%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Reserves as a percentage of risk
in-force
as of December 31, 2023 decreased compared to December 31, 2022 as long-term delinquencies with higher reserves have continued to cure. The number of loans that are delinquent for 12 months or more has decreased since December 31, 2022 and is more in line with

pre-COVID-19

levels. Due to continued forbearance options, foreclosure moratoriums and the uncertainty

88

Table of Contents

around the lack of progression through the foreclosure process, there is still uncertainty around the likelihood and timing of delinquencies going to claim.

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk
in-force
as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender.

Percent of primary risk in-force as of December 31, 2023Percent of direct primary case reserves as of December 31, 2023(1)Delinquency rate as of December 31,
202320222021
By State:
California13%12%2.22%2.09%3.17%
Texas8%8%2.22%2.12%2.89%
Florida(2)8%9%2.39%2.54%2.97%
New York(2)5%12%3.05%2.95%3.80%
Illinois(2)4%6%2.61%2.54%3.09%
Arizona4%3%1.93%1.78%2.31%
Michigan4%3%1.94%1.79%1.87%
Georgia3%4%2.23%2.23%2.94%
North Carolina3%2%1.56%1.59%2.18%
Washington3%2%1.77%1.92%2.98%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
Column 1Column 2
(2)Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.
Percent of primary risk in-force as of December 31, 2023Percent of direct primary case reserves as of December 31, 2023(1)Delinquency rate as of December 31,
202320222021
By MSA or MD:
Phoenix, AZ MSA3%2%2.01%1.83%2.36%
Chicago-Naperville, IL MD3%4%2.88%2.84%3.68%
Atlanta, GA MSA3%3%2.40%2.42%3.28%
New York, NY MD2%7%3.60%3.75%5.32%
Washington-Arlington, DC MD2%2%2.01%1.85%2.96%
Houston, TX MSA2%3%2.67%2.60%3.61%
Los Angeles-Long Beach, CA MD2%3%2.39%2.18%3.95%
Dallas, TX MD2%2%1.92%1.86%2.31%
Riverside-San Bernardino, CA MSA2%3%2.83%2.89%3.42%
Denver-Aurora-Lakewood, CO MSA2%1%1.12%1.12%1.66%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout

89

Table of Contents

specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance,
pre-foreclosure
sale and

deed-in-lieu.

These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.

The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance
in-force
and risk
in-force
by year of policy origination, weighted average mortgage interest rate and delinquency rate as of December 31, 2023:

(Amounts in millions)Weighted average rate (1)Percent of direct primary case reserves(2)Primary insurance in-forcePercent of totalPrimary risk in-forcePercent of totalDelinquency rate
Policy Year
2008 and prior5.74%18%$5,6212%$1,4492%8.61%
2009 to 20154.34%43,383188114.55%
20163.94%44,65921,24823.20%
20174.30%55,32121,40323.59%
20184.82%65,75021,47624.42%
20194.25%813,77353,54452.77%
20203.27%1544,4861711,697171.70%
20213.11%2170,0452717,846271.65%
20224.89%1659,2672314,907221.57%
20236.68%350,6321913,078200.47%
Total portfolio4.41%100%$262,937100%$67,529100%2.10%
Column 1Column 2
(1)Average annual mortgage interest rate weighted by insurance in-force.
Column 1Column 2
(2)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk
in-force.
The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. Loss reserves have shifted to newer book years, largely 2020 and later given their significant representation of risk
in-force.
As of December 31, 2023, Enact’s 2016 and newer policy years represented approximately 97% of its primary risk
in-force
and 78% of its total direct primary case reserves.

The ratio of the claim paid to the current risk
in-force
for a loan is referred to as “claim severity.” The current risk
in-force
is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws.
Pre-foreclosure
sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 97%, 94% and 103% for the years ended December 31, 2023, 2022 and 2021, respectively. The average claim severity for the years ended December 31, 2023 and 2022 was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on
non-performing
loans.

Long-Term Care Insurance segment

Trends and conditions

The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to
in-force
rate actions,

90

Table of Contents

morbidity, mortality and persistency. Estimates for
in-force
rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively.

Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on our oldest long-term care insurance blocks of business will continue to decrease as the blocks run off, we are gaining more experience on our larger new blocks of business and fully expect continued overall growth in new claims as policyholders reach their peak claim years. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. Increases in cost of care have resulted in higher claim payments in our long-term care insurance business, which could have a material adverse impact on our liquidity, results of operations and financial condition if it persists. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.

Under LDTI, the impacts of assumption updates and actual versus expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. It is important to note that quarterly variations resulting from assumption updates and actual versus expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $42.2 billion, at the
locked-in
discount rate, for our long-term care insurance business as of December 31, 2023.

For a discussion of potential impacts of assumption updates and actual versus expected experience on our results of operations, see “Item 1A—Risk Factors—We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition.”

The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and related reinsurance recoverables at the
single-A
bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.”

In-force
rate actions and legal settlements

Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our
in-force
policies. Executing on our multi-year long-term care insurance
in-force
rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on
in-force
rate actions, refer to the selected operating performance measures below.

91

Table of Contents

In addition, we have reached certain legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. The first legal settlement related to certain of our long-term care insurance policies, which represents approximately 20% of our block, was implemented beginning in 2021 and its implementation was materially completed in the second quarter of 2022. A second legal settlement on certain of our long-term care insurance policies, which represents 15% of our block, was implemented beginning in August 2022 and its implementation was materially completed in the fourth quarter of 2023. On March 27, 2023, a third similar settlement on certain of our long-term care insurance policies, which represents 35% of our block, became final. We began implementation of this settlement during the second quarter of 2023.

While the legal settlements are similar, their ultimate impact will depend on the policyholder election rates and the types of reduced benefits elected. Given our experience with the first and second settlements, we expect the third legal settlement to result in an overall net favorable economic impact to our long-term care insurance business as it reduces tail risk on these long-duration liabilities. While we expect renewal premiums to decline over time, the settlements could accelerate that decline if policyholders continue to elect
non-forfeiture
and reduced benefit options, which have predominantly been the most prevalent policyholder elections for these legal settlements and which entitle the policyholder to reduced benefits in exchange for premiums already paid or a lower level of future premiums.

Fourth quarter assumption review

In the fourth quarter of 2023, our long-term care insurance products had an unfavorable
pre-tax
impact of $61 million from cash flow assumption updates, including updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse. For our 2023 assumption updates, we generally did not include data after 2019 in setting any long-term assumptions, as we do not have sufficient information around longer-term effects of the pandemic, which is consistent with the approach for our 2022 assumptions. However, we made a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year
in-force
rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. We also updated our assumptions for the third legal settlement in the fourth quarter of 2023; however, the changes had a muted favorable income statement impact as this settlement impacts profitable uncapped cohorts.

In the fourth quarter of 2022, our long-term care insurance business had favorable assumption updates of $303 million, which reflected an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. This settlement primarily impacts older, unprofitable capped cohorts; therefore, it had an immediate impact to the fourth quarter of 2022 earnings.

Under statutory accounting, only changes to our claim reserve assumptions are reflected in statutory income. Assumption changes impacting active life reserves are included in cash flow testing margin, which only impacts statutory income if the margin falls below zero. We completed statutory cash flow testing for our life insurance subsidiaries in the fourth quarter of 2023 and concluded that the margin in GLIC was positive and within the $0.5 billion to $1.0 billion range. However, GLICNY had a negative margin and recorded additional statutory reserves of $87 million in 2023.

COVID-19
impacts

In our long-term care insurance products, we experienced a favorable impact on reserves and our operating results related to elevated mortality during
COVID-19.
Although it is not our practice to track cause of death for long-term care insurance policyholders and claimants, we believe the favorable mortality in our long-term care

92

Table of Contents

insurance business in early 2022 was likely impacted by
COVID-19.
We expected the impacts to be temporary, with disabled life mortality remaining elevated over the near term. We saw mortality levels trending back to
pre-pandemic
levels in the latter half of 2022. In the first quarter of 2023, we experienced typical seasonally favorable mortality, but mortality was unfavorable for the remainder of 2023, consistent with seasonal trends.

We also experienced lower than expected new claims incidence in our long-term care insurance business during
COVID-19.
However, we are seeing new claims incidence trending back to
pre-pandemic
levels. In addition, during the pandemic, a larger share of our claimants sought home care instead of facility-based care, and as the impacts of the pandemic subside, we have seen that trend reverse. We will continue to monitor long-term care insurance benefit utilization so that we can evaluate any long-term impact emerging from the pandemic.

While the longer-term impacts of
COVID-19
are very difficult to predict, the related outcomes and impact on our long-term care insurance business currently depend on the after-effects indirectly caused by the pandemic, including elevated inflation, the associated impacts to the cost of care and changes in policyholder behavior. We will continue to monitor
COVID-19
associated impacts and evaluate all of our assumptions that may need updating as a result of longer-term trends related to the pandemic.

93

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$2,463$2,500$2,561$(37)(1)%$(61)(2)%
Net investment income1,9141,9002,027141%(127)(6)%
Net investment gains (losses)1141925795NM(1)(238)(93)%
Policy fees and other income1— %(1)(100)%
Total revenues4,4914,4194,846722%(427)(9)%
Benefits and expenses:
Benefits and other changes in policy reserves3,8023,7883,80814— %(20)(1)%
Liability remeasurement (gains) losses321(317)68638NM(1)(385)NM(1)
Acquisition and operating expenses, net of deferrals452413451399%(38)(8)%
Amortization of deferred acquisition costs and intangibles717476(3)(4)%(2)(3)%
Total benefits and expenses4,6463,9584,40368817%(445)(10)%
Income (loss) from continuing operations before income taxes(155)461443(616)(134)%184%
Provision (benefit) for income taxes(3)125123(128)(102)%22%
Income (loss) from continuing operations(152)336320(488)(145)%165%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses(114)(19)(257)(95)NM(1)23893%
Expenses related to restructuring(1)121100%(13)(108)%
Taxes on adjustments2445120NM(1)(47)(92)%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$(242)$320$126$(562)(176)%$194154%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2023 compared to 2022

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022. The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to the second legal settlement. We also experienced higher operating costs and lower premiums in 2023.

Revenues

Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering
paid-up
status, partially offset by $70 million of higher premiums from newly implemented
in-force
rate actions in 2023.

94

Table of Contents

Net investment income increased largely due to higher investment yields and higher income from limited partnerships and bank loans, partially offset by lower income from U.S. Government Treasury Inflation Protected Securities (“TIPS”). The increase was also partially offset by lower income from bond calls and commercial mortgage loan prepayments in 2023.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves increased primarily due to aging of the
in-force
block, including higher interest accretion, as well as higher loss adjustment expenses, partially offset by policy terminations in 2023.

The liability remeasurement loss in 2023 was largely driven by adverse actual versus expected experience primarily related to higher claims and unfavorable timing impacts from the second legal settlement. In addition, cash flow assumption updates were unfavorable in 2023 primarily driven by unfavorable updates to our healthy life assumptions to better reflect near-term experience related to cost of care, mortality, incidence and lapse. This was partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
The liability remeasurement gain in 2022 resulted primarily from favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement.

Acquisition and operating expenses, net of deferrals, increased principally from higher operating costs, partially offset by a lower accrual for legal settlement costs in 2023.

Provision (benefit) for income taxes.

The effective tax rate was 2.2% and 27.2% for the years ended December 31, 2023 and 2022, respectively. The decrease in the effective tax rate was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income in relation to a
pre-tax
loss in 2023.

2022 compared to 2021

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, partially offset by lower net investment income in 2022.

Revenues

Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering
paid-up
status, partially offset by $93 million of higher premiums from newly implemented
in-force
rate actions in 2022.

Net investment income decreased largely from lower income of $169 million in 2022 mostly attributable to limited partnerships, as well as bond calls and commercial mortgage loan prepayments. The decrease was partially offset by higher income of $18 million from TIPS and higher average invested assets in 2022.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

95

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves decreased primarily due to policy terminations, partially offset by aging of the
in-force
block, including higher interest accretion, as well as higher loss adjustment expenses in 2022.

The liability remeasurement gain in 2022 was largely related to favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. The liability remeasurement loss in 2021 was primarily driven by unfavorable cash flow assumption updates largely related to an update to the benefit utilization trend to reflect expected future increases in cost of care, which drove significant updates to the
in-force
rate action plan and related assumptions. The unfavorable assumption updates in 2021 were partially offset by favorable actual to expected experience related to claim terminations and
in-force
rate actions.

Acquisition and operating expenses, net of deferrals, decreased principally from lower operating costs in 2022 and restructuring costs of $12 million in 2021 that did not recur, partially offset by a $20 million accrual for legal settlement costs in 2022.

Provision (benefit) for income taxes.

The effective tax rate was 27.2% and 27.9% for the years ended December 31, 2022 and 2021, respectively.

Long-Term Care Insurance selected operating performance measures

Under LDTI, we now include expectations for benefit reductions related to
in-force
rate actions and legal settlements as well as settlement payments in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. There was no change in how we recognize premiums related to
in-force
rate actions due to the adoption of LDTI.

We have experienced and may continue to experience quarterly fluctuations in earnings related to the legal settlements to the extent actual experience deviates from our assumptions. However, we expect the legal settlements to result in an overall net favorable economic impact to our long-term care insurance business as they reduce tail risk on these long-duration liabilities.

Under LDTI, we elected to update the net premium ratio quarterly for actual versus expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions and settlement payments will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis.

Remeasurement (gains) losses

The following table sets forth the
pre-tax
components of the liability remeasurement (gains) losses for the periods indicated:

Years ended December 31(Increase) decrease and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Cash flow assumption updates$52$(335)$227$387116%$(562)NM(1)
Actual to expected experience26918(159)251NM(1)177111%
Total liability remeasurement (gains) losses$321$(317)$68$638NM(1)$(385)NM(1)
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

96

Table of Contents

For additional discussion of the change in liability remeasurement (gains) losses, see the comparison for this line item above in “—Segment results of operations.”

In-force
rate actions

As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to ensure the continued self-sustainability of our long-term care insurance business over time and reduce the strain on its earnings and capital.

The following table sets forth filing approvals as part of our multi-year
in-force
rate action plan for the years ended December 31:

(Dollar amounts in millions)202320222021
State filings approved117139173
Impacted in-force premiums$697$1,143$1,095
Weighted-average percentage rate increase approved51%48%37%
Gross incremental premiums approved$354$549$403

We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year
in-force
rate action plan from 2012 through December 31, 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements. The $28.0 billion net present value of progress achieved has grown significantly since December 31, 2022, including $2.0 billion of value from rate action approvals and settlement implementations in 2023 and an increase of $2.5 billion of the value of benefit reductions connected with our previously achieved rate actions and settlements, including the impact of our assumption updates.

During the year ended December 31, 2023, we also submitted 144 new filings on approximately $989 million in annualized
in-force
premiums.

The approval process for
in-force
rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider litigation against states that decline to approve those actuarially justified rate increases. In January 2022, we began litigation with two states that have refused to approve actuarially justified rate increases.

Life and Annuities segment

Trends and conditions

Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the

97

Table of Contents

past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves.

Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.”

Life insurance

Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors.

Mortality levels may deviate each period from historical trends. Overall mortality experience was less unfavorable during 2023 as compared to 2022. In our life insurance products,
COVID-19
deaths significantly declined during 2023 from the levels in 2022. We have experienced unfavorable mortality compared to our then-current and
priced-for
assumptions in recent years for our universal life insurance block. We have also been experiencing higher mortality related charges resulting in an increase in rates charged by our reinsurance partners reflecting natural block aging and unfavorable mortality compared to expectations.

In the fourth quarter of 2023, our life insurance products had an unfavorable impact from cash flow assumption updates of $226 million reflecting updates to our persistency and mortality assumptions. We made an unfavorable update to our persistency assumptions particularly in certain universal life insurance products with secondary guarantees to better reflect emerging experience, consistent with others in the industry. However, given the relatively small size and characteristics of our closed block, we believe we experienced a smaller impact from our assumption updates relative to others in the industry with larger blocks. We also made unfavorable updates to our mortality assumption in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
Our 2023 assumption review considered trends during the pandemic years, but updates to our long-term assumptions generally excluded experience data after 2019, as we do not have sufficient information around the long-term effects of
COVID-19.
However, similar to our long-term care insurance products, we assessed near-term mortality trends as we continue to evaluate the long-term implications of
COVID-19.

In 2022, we made favorable cash flow assumption updates of $37 million in our universal and term universal life insurance products primarily related to higher interest rates.

Certain of our universal life insurance products with secondary guarantees are subject to additional reserves on a statutory basis using a regulatory prescribed reinvestment rate. Given the increase in rates, we experienced a favorable benefit from the reinvestment rate in 2023, which more than offset negative assumption updates from a statutory income perspective.

Fixed annuities

Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels.

We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.

98

Table of Contents

As part of our fourth quarter of 2023 review of our cash flow assumptions, we focused on mortality and lapse assumptions in our fixed annuity products and made modest updates based on recent experience.

For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.

Variable annuities

Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.

Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity and interest rate market performance and volatility could result in additional gains or losses in these products although associated hedging activities are expected to partially mitigate these impacts.

99

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$207$234$(136)$(27)(12)%$370NM(1)
Net investment income1,0421,0831,195(41)(4)%(112)(9)%
Net investment gains (losses)(49)(4)74(45)NM(1)(78)(105)%
Policy fees and other income646669718(23)(3)%(49)(7)%
Total revenues1,8461,9821,851(136)(7)%1317%
Benefits and expenses:
Benefits and other changes in policy reserves96362064834355%(28)(4)%
Liability remeasurement (gains) losses26627174239NM(1)(147)(84)%
Changes in fair value of market risk benefits and associated hedges(12)(104)(160)9288%5635%
Interest credited503504511(1)%(7)(1)%
Acquisition and operating expenses, net of deferrals213604233(391)(65)%371159%
Amortization of deferred acquisition costs and intangibles181240291(59)(25)%(51)(18)%
Total benefits and expenses2,1141,8911,69722312%19411%
Income (loss) from continuing operations before income taxes(268)91154(359)NM(1)(63)(41)%
Provision (benefit) for income taxes(59)1630(75)NM(1)(14)(47)%
Income (loss) from continuing operations(209)75124(284)NM(1)(49)(40)%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses494(74)45NM(1)78105%
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2)(22)(142)(210)12085%6832%
Expenses related to restructuring(1)51100%(6)(120)%
Pension plan termination costs8(8)(100)%8NM(1)
Taxes on adjustments(6)2859(34)(121)%(31)(53)%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(188)$(28)$(96)$(160)NM(1)$6871%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)For the years ended December 31, 2023, 2022 and 2021, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million, respectively.

100

Table of Contents

The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage changeIncrease (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Life insurance$(275)$(111)$(201)$(164)(148)%$9045%
Fixed annuities506283(12)(19)%(21)(25)%
Variable annuities3721221676%(1)(5)%
Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(188)$(28)$(96)$(160)NM(1)$6871%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2023 compared to 2022

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance products increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023. These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 that did not recur.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience in 2023.
Column 1Column 2Column 3Column 4
Adjusted operating income in our variable annuity products increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 2023.

Revenues

Premiums

. The decrease was driven by our life insurance products largely due to the continued runoff of our
in-force
blocks in 2023.

Net investment income

.

The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, partially offset by higher investment yields in 2023.

Net investment gains (losses)

. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Policy fees and other income.

The decrease was principally from lower fee income due mostly to a decline in average account value in our variable annuity products and from lower product charges in our life insurance products due to the runoff of our
in-force
blocks in 2023.

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our fixed annuity products increased $352 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts in 2022 that did not recur, partially offset by favorable mortality in 2023.

101

Table of Contents

Column 1Column 2Column 3Column 4
Our life insurance products decreased $11 million primarily from less unfavorable mortality, partially offset by an increase in cost of reinsurance reserves related to a ceded reinsurance transaction in the fourth quarter of 2023.

Liability remeasurement (gains) losses

. The increase in the liability remeasurement loss was largely attributable to a $244 million increase in our life insurance products principally driven by unfavorable updates to our persistency assumptions for certain universal life insurance products with secondary guarantees and unfavorable mortality updates, including more modest mortality improvement, in our term universal, universal and term life insurance products. The unfavorable assumption updates were partially offset by net favorable impacts related to a ceded reinsurance transaction in the fourth quarter of 2023.

Changes in fair value of market risk benefits and associated hedges

Column 1Column 2Column 3Column 4
Our variable annuity products had an unfavorable variance of $50 million principally driven by higher derivative losses and lower interest rate increases, partially offset by favorable equity market impacts as well as lower attributed fees and higher benefit payments due to aging of our in-force block in 2023.
Column 1Column 2Column 3Column 4
Our fixed annuity products had an unfavorable variance of $42 million primarily attributable to lower interest rate increases, partially offset by favorable equity market impacts in 2023.

Acquisition and operating expenses, net of deferrals

Column 1Column 2Column 3Column 4
Our fixed annuity products decreased $363 million primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party.
Column 1Column 2Column 3Column 4
Our life insurance products decreased $23 million primarily due to a legal settlement expense of $25 million and pension plan termination costs of $8 million in 2022 that did not recur. These decreases were partially offset by higher costs associated with an outsourcing arrangement in 2023.

Amortization of deferred acquisition costs and intangibles.

The decrease was primarily related to our life insurance products largely due to higher lapses in 2022 as our
20-year
level premium period business written in 2002 entered its post-level premium period.

Provision for income taxes.

The effective tax rate was 22.1% and 18.2% for the years ended December 31, 2023 and 2022, respectively. The increase in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to a
pre-tax
loss in 2023.

2022 compared to 2021

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance products decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality. The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022.
Column 1Column 2Column 3Column 4
Adjusted operating income in our variable annuity products was relatively flat in 2022 compared to 2021.

Revenues

Premiums

. The increase was driven by our life insurance products largely due to lower ceded premiums, partially offset by the continued runoff of our
in-force
blocks in 2022. In 2021, we ceded $360 million of certain term life insurance premiums in connection with a reinsurance transaction.

102

Table of Contents

Net investment income

.

The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, as well as lower bond calls and commercial mortgage loan prepayments in 2022.

Net investment gains (losses)

. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Policy fees and other income.

The decrease was principally from lower product charges in our life insurance products driven mostly by the runoff of our
in-force
blocks and lower fee income in our variable annuity products driven mostly by a decline in average account value in 2022.

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our fixed annuity products decreased $395 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts and from favorable mortality in 2022.
Column 1Column 2Column 3Column 4
Our life insurance products increased $352 million primarily from higher ceded reinsurance in 2021, partially offset by favorable mortality experience in 2022. We ceded $360 million of certain term life insurance reserves in connection with a reinsurance transaction in 2021.
Column 1Column 2Column 3Column 4
Our variable annuity products increased $15 million primarily from unfavorable equity market performance and aging of the in-force block in 2022.

Liability remeasurement (gains) losses

Column 1Column 2Column 3Column 4
The liability remeasurement loss in our life insurance products decreased $117 million mainly attributable to favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 compared to unfavorable updates in 2021. The favorable cash flow assumption updates in 2022 were primarily related to higher interest rates. The unfavorable cash flow assumption updates in 2021 were primarily driven by unfavorable pre-COVID-19 mortality.
Column 1Column 2Column 3Column 4
Our fixed annuity products had a liability remeasurement gain of $5 million in 2022 compared to a loss of $25 million in 2021. The liability remeasurement loss in 2021 was largely driven by unfavorable mortality assumption updates.

Changes in fair value of market risk benefits and associated hedges

Column 1Column 2Column 3Column 4
Our variable annuity products had an unfavorable variance of $75 million principally driven by unfavorable equity market impacts, partially offset by higher interest rates and derivative gains in 2022.
Column 1Column 2Column 3Column 4
Our fixed annuity products had a favorable variance of $19 million primarily attributable to higher interest rates, partially offset by unfavorable equity market impacts in 2022.

Acquisition and operating expenses, net of deferrals.

The increase was largely attributable to our fixed annuity products primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party.

Amortization of deferred acquisition costs and intangibles.

The decrease was primarily driven by lapse experience in our term life insurance products.

Provision for income taxes.

The effective tax rate was 18.2% and 19.8% for the years ended December 31, 2022 and 2021, respectively.

103

Table of Contents

Life and Annuities selected operating performance measures

Life insurance

The following table sets forth selected operating performance measures regarding our life insurance products as of the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 2022
Term and whole life insurance
Life insurance in-force, net of reinsurance$44,121$48,162$47,297$(4,041)(8)%
Life insurance in-force, before reinsurance$270,950$300,145$332,793$(29,195)(10)%
Term universal life insurance
Life insurance in-force, net of reinsurance$90,427$92,719$99,471$(2,292)(2)%
Life insurance in-force, before reinsurance$91,024$93,336$100,119$(2,312)(2)%
Universal life insurance
Life insurance in-force, net of reinsurance$28,710$29,798$31,117$(1,088)(4)%
Life insurance in-force, before reinsurance$32,199$33,622$35,228$(1,423)(4)%

The decrease in insurance
in-force
in our life insurance products reflects the continued runoff of our
in-force
blocks.

104

Table of Contents

Corporate and Other

Results of operations

The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$9$6$6$350%$— %
Net investment income198711138%114%
Net investment gains (losses)(28)(15)(7)(13)(87)%(8)(114)%
Policy fees and other income(2)1(2)NM(1)(1)(100)%
Total revenues(2)(1)7(1)(100)%(8)(114)%
Benefits and expenses:
Benefits and other changes in policy reserves(9)(11)(6)218%(5)(83)%
Acquisition and operating expenses, net of deferrals6541842459%(43)(51)%
Amortization of deferred acquisition costs and intangibles121NM(1)(2)(100)%
Interest expense66541091222%(55)(50)%
Total benefits and expenses123841893946%(105)(56)%
Loss from continuing operations before income taxes(125)(85)(182)(40)(47)%9753%
Benefit for income taxes(20)(16)(53)(4)(25)%3770%
Loss from continuing operations(105)(69)(129)(36)(52)%6047%
Adjustments to loss from continuing operations:
Net investment (gains) losses281571387%8114%
(Gains) losses on early extinguishment of debt(2)645(8)(133)%(39)(87)%
Expenses related to restructuring41143NM(1)(13)(93)%
Taxes on adjustments(6)(5)(13)(1)(20)%862%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(81)$(52)$(76)$(29)(56)%$2432%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2023 compared to 2022

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023.

Revenues

Net investment income increased largely from higher investment yields in 2023.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

105

Table of Contents

Benefits and expenses

Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives and higher employee-related expenses, partially offset by gains on the early extinguishment of certain of Genworth Holdings’ debt in 2023 compared to losses in 2022.

Interest expense increased largely driven by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2023, partially offset by the early redemption in 2022 of Genworth Holdings’ senior notes due in 2024.

The benefit for income taxes increased primarily related to a higher
pre-tax
loss in 2023, partially offset by a state tax benefit in 2022 that did not recur.

2022 compared to 2021

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

Revenues

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves decreased primarily related to inter-segment transactions.

Acquisition and operating expenses, net of deferrals, decreased mainly driven by $24 million of lower make-whole premiums on the early redemption of Genworth Holdings’ senior notes and $15 million of lower net losses related to the repurchase of Genworth Holdings’ senior notes in 2022, as well as $13 million of lower restructuring costs. These decreases were partially offset by higher expenses related to CareScout growth initiatives in 2022.

Interest expense decreased largely driven by the early redemption and repurchase of Genworth Holdings’ senior notes due in September 2021, August 2023 and February 2024, partially offset by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2022.

The decrease in the benefit for income taxes was primarily related to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur, as well as a lower
pre-tax
loss in 2022.

Investments and Derivative Instruments

Trends and conditions

Investments

During the year ended December 31, 2023, our investments portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends.

Column 1Column 2Column 3Column 4
The U.S. Federal Reserve increased interest rates by 100 basis points, bringing the upper end of the target range to the highest level since 2001.

106

Table of Contents

Column 1Column 2Column 3Column 4
During the fourth quarter of 2023, the ten-year U.S. Treasury yield rose to its highest level since 2007, but U.S. Treasury yields decreased compared to September 30, 2023. Although the two-year U.S. Treasury yield remained above the ten-year U.S. Treasury yield in 2023, the differential between the two-year yield and the ten-year yield declined compared to December 31, 2022.
Column 1Column 2Column 3Column 4
Credit spreads tightened and credit market performance remained resilient as macroeconomic data continued to support market optimism for a soft economic landing in 2023.
Column 1Column 2Column 3Column 4
Bank deposits stabilized in the second half of 2023 after three regional banks were taken into receivership by the Federal Deposit Insurance Corporation in early 2023. At this time, we believe our investment portfolio is well positioned and any risks to valuations as a result of the pressures in the regional banking system and commercial real estate are manageable.
Column 1Column 2Column 3Column 4
As of December 31, 2023, our fixed maturity securities portfolio, which was 96% investment grade, comprised 75% of our total invested assets and cash.

Derivatives

Column 1Column 2Column 3Column 4
As of December 31, 2023, $1.3 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”).
Column 1Column 2Column 3Column 4
The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2023, we posted initial margin of $79 million to our clearing agents, which represented $39 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings.
Column 1Column 2Column 3Column 4
As of December 31, 2023, $11.4 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $464 million and are holding collateral from counterparties in the amount of $19 million.

107

Table of Contents

Investment results

The following table sets forth information about our investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:

Increase (decrease)
2023202220212023 vs. 20222022 vs. 2021
(Amounts in millions)YieldAmountYieldAmountYieldAmountYieldAmountYieldAmount
Fixed maturity securities— taxable4.5%$2,2444.5%$2,2964.5%$2,411%$(52)%$(115)
Fixed maturity securities— non-taxable4.2%34.7%55.6%7(0.5)%(2)(0.9)%(2)
Equity securities3.0%114.0%104.0%9(1.0)%1%1
Commercial mortgage loans4.4%3024.6%3215.5%376(0.2)%(19)(0.9)%(55)
Policy loans10.2%22410.0%2119.3%1890.2%130.7%22
Limited partnerships (1)4.5%1174.7%9915.7%223(0.2)%18(11.0)%(124)
Other invested assets (2)50.5%27959.9%26769.7%241(9.4)%12(9.8)%26
Cash, cash equivalents, restricted cash and short-term investments4.7%951.2%20%13.5%751.2%19
Gross investment income before expenses and fees5.1%3,2755.0%3,2295.2%3,4570.1%46(0.2)%(228)
Expenses and fees(0.2)%(92)(0.2)%(83)(0.1)%(87)%(9)(0.1)%4
Net investment income4.9%$3,1834.8%$3,1465.1%$3,3700.1%$37(0.3)%$(224)
Average invested assets and cash$64,637$65,160$66,099$(523)$(939)
Column 1Column 2
(1)Limited partnership investments are primarily equity-based and do not have fixed returns by period.
Column 1Column 2
(2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments and securities lending activity, which was included in other invested assets prior to the suspension of our securities lending program in the third quarter of 2021 and was calculated net of the corresponding securities lending liability.

Gross annualized weighted-average investment yields increased in 2023 compared to 2022 primarily driven by higher investment income on lower average invested assets. Net investment income included higher returns of $75 million primarily on our short-term investments due to higher interest rates, $18 million of higher limited partnership income and $15 million of higher income from bank loans, partially offset by $41 million of lower income related to inflation-driven volatility on TIPS and $26 million of lower bond calls and commercial mortgage loan prepayments.

Gross annualized weighted-average investment yields decreased in 2022 compared to 2021 primarily driven by lower net investment income on lower average invested assets. Net investment income included $124 million of lower limited partnership income and $106 million of lower bond calls and commercial mortgage loan prepayments, partially offset by $18 million of higher income related to inflation-driven volatility on TIPS in 2022.

108

Table of Contents

The following table sets forth net investment gains (losses) for the years ended December 31:

(Amounts in millions)202320222021
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains$29$28$67
Realized losses(154)(102)(10)
Net realized gains (losses) on available-for-sale fixed maturity securities(125)(74)57
Net realized gains (losses) on equity securities sold(1)(7)
Net realized gains (losses) on limited partnerships3
Total net realized investment gains (losses)(126)(74)53
Net change in allowance for credit losses on available-for-sale fixed maturity securities(7)(6)
Write-down of available-for-sale fixed maturity securities(1)(2)(1)
Net unrealized gains (losses) on equity securities still held53(35)1
Net unrealized gains (losses) on limited partnerships11171264
Commercial mortgage loans(5)4(3)
Derivative instruments73213
Other(9)21
Net investment gains (losses)$23$(2)$322

2023 compared to 2022

Column 1Column 2Column 3Column 4
We recorded $125 million of net losses related to the sale of available-for-sale fixed maturity securities in 2023 compared to $74 million in 2022. The net losses in 2023 were primarily related to portfolio repositioning and liquidity management, as well as regional bank exposure management, including a $15 million loss related to the sale of First Republic Bank U.S. corporate bonds.
Column 1Column 2Column 3Column 4
We recorded net unrealized gains on equity securities of $53 million in 2023 driven by favorable equity market performance compared to net unrealized losses of $35 million in 2022 from unfavorable performance. We recorded $40 million of higher net unrealized gains on limited partnerships driven by more favorable private equity market performance in 2023. We also recorded an allowance for credit losses on available-for-sale fixed maturity securities of $7 million in 2023.
Column 1Column 2Column 3Column 4
Net investment gains related to derivatives decreased in 2023 primarily from losses on hedging programs that support our fixed indexed annuity products compared to gains in 2022, lower gains on hedging programs that support our indexed universal life insurance products and losses from forward bond purchase commitments in 2023. These decreases were partially offset by gains on equity index options in 2023 compared to losses in 2022.

2022 compared to 2021

Column 1Column 2Column 3Column 4
We recorded net realized losses related to the sale of available-for-sale fixed maturity securities of $74 million in 2022 compared to net realized gains of $57 million in 2021 primarily driven by sales of U.S. corporate securities to manage asset exposure and to optimize cash at Genworth Holdings in 2022.
Column 1Column 2Column 3Column 4
We recorded $193 million of lower net unrealized gains on limited partnerships in 2022 compared to 2021 primarily from less favorable private equity market performance in 2022. We also recorded $35 million of net unrealized losses on equity securities during 2022 driven by unfavorable equity market performance.

109

Table of Contents

Investment portfolio

The following table sets forth our cash, cash equivalents and invested assets as of December 31:

20232022
(Amounts in millions)Carrying value% of totalCarrying value% of total
Available-for-sale fixed maturity securities:
Public$32,18951%$31,75753%
Private14,5922414,82624
Equity securities39613191
Commercial mortgage loans, net6,802107,01011
Policy loans2,22042,1393
Limited partnerships2,82152,3314
Other invested assets73115661
Cash, cash equivalents and restricted cash2,21541,7993
Total cash, cash equivalents and invested assets$61,966100%$60,747100%

For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 5 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2023, approximately 7% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 21 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.

110

Table of Contents

The following table presents our public, private and total fixed maturity securities by the Nationally Recognized Statistical Rating Organizations (“NRSRO”) designations and/or equivalent ratings, as well as the percentage, based upon fair value that each designation comprises. Certain fixed maturity securities that are not rated by an NRSRO are shown based upon internally prepared credit evaluations.

As of December 31,
(Amounts in millions)20232022
NRSRO designationAmortized costFair value% of totalAmortized costFair value% of total
Public fixed maturity securities
AAA$2,779$2,5598%$6,394$6,06719%
AA6,4616,170193,1462,8599
A9,4749,287298,8608,39827
BBB14,34613,6454214,96413,62343
BB51849828397762
B32303734
CCC and lower
Total public fixed maturity securities$33,610$32,189100%$34,240$31,757100%
Private fixed maturity securities
AAA$866$8326%$876$8256%
AA1,5741,477101,5621,42110
A4,3984,043284,6754,17028
BBB7,7097,126488,1297,22148
BB1,03797571,2171,0767
B14911711351131
CCC and lower77
Not rated1515
Total private fixed maturity securities$15,755$14,592100%$16,594$14,826100%
Total fixed maturity securities
AAA$3,645$3,3917%$7,270$6,89215%
AA8,0357,647164,7084,2809
A13,87213,3302913,53512,56827
BBB22,05520,7714523,09320,84445
BB1,5551,47332,0561,8524
B181147172147
CCC and lower77
Not rated1515
Total fixed maturity securities$49,365$46,781100%$50,834$46,583100%

We invest in privately placed fixed maturity securities to increase diversification and obtain higher yields than can ordinarily be obtained with comparable public market securities. Generally, private placements provide us with protective covenants, call protection features and, where applicable, a higher level of collateral. However, our private placements are not as freely transferable as public securities because of restrictions imposed by federal and state securities laws, the terms of the securities and the characteristics of the private market. Based upon fair value, public fixed maturity securities represented 69% and 68%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022. Private fixed maturity securities represented 31% and 32%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022.

We diversify our corporate securities by industry and issuer. As of December 31, 2023, our combined holdings in the 10 corporate issuers to which we had the greatest exposure was $1.8 billion, which was

111

Table of Contents

approximately 3% of our total cash, cash equivalents and invested assets. The exposure to the largest single corporate issuer held as of December 31, 2023 was $273 million, which was less than 1% of our total cash, cash equivalents and invested assets. See note 5 to our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on diversification by sector.

Other invested assets

The following table sets forth the carrying values of our other invested assets as of December 31:

20232022
(Amounts in millions)Carrying value% of totalCarrying value% of total
Bank loan investments$52972%$46782%
Derivatives13118509
Short-term investments27431
Other investments446468
Total other invested assets$731100%$566100%

Bank loan investments increased from funding of additional investments, partially offset by principal payments in 2023. Derivatives increased largely from higher contracted notional interest rates on forward bond purchase commitments in excess of current market rates.

112

Table of Contents

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:

(Notional in millions)MeasurementDecember 31, 2022AdditionsMaturities/ terminationsDecember 31, 2023
Derivatives designated as hedges
Cash flow hedges:
Interest rate swapsNotional$8,542$1,857$(1,424)$8,975
Foreign currency swapsNotional144(13)131
Forward bond purchase commitmentsNotional1,0751,075
Total cash flow hedges8,6862,932(1,437)10,181
Total derivatives designated as hedges8,6862,932(1,437)10,181
Derivatives not designated as hedges
Equity index optionsNotional936729(963)702
Financial futuresNotional1,4035,488(5,640)1,251
Forward bond purchase commitmentsNotional500500
Total derivatives not designated as hedges2,3396,717(6,603)2,453
Total derivatives$11,025$9,649$(8,040)$12,634
(Number of policies)MeasurementDecember 31, 2022AdditionsMaturities/ terminationsDecember 31, 2023
Derivatives not designated as hedges
Fixed indexed annuity embedded derivativesPolicies7,315(1,489)5,826
Indexed universal life embedded derivativesPolicies771(22)749

The increase in the notional value of derivatives was primarily attributable to the addition of forward bond purchase commitments and interest rate swaps that support our long-term care and universal life insurance businesses, partially offset by a decrease in equity index options used to support our fixed indexed annuity products.

The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to runoff.

Critical Accounting Estimates

The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” For a detailed discussion of our significant accounting policies, see note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

113

Table of Contents

The sensitivities in the tables below are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products. The impacts are discrete and do not reflect the impact one factor may have on another. In any period and over time, our actual experience may have a positive or negative variance from our long-term assumptions, either singularly or collectively, and these variances may offset each other.

Liability for future policy benefits

The measurement of the liability for future policy benefits reflects estimates and actuarial assumptions and methodologies which involve the exercise of significant judgment and are inherently uncertain. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Establishing assumptions for the liability for future policy benefits is complex and involves many factors. Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding loss recognized in net income (loss). Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our liability for future policy benefits. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Moreover, for our long-term care insurance products, we may not be able to mitigate the impact of unexpected adverse experience by increasing premiums and/or other charges to policyholders (where we have the right to do so) or by offering benefit reductions as an alternative to increasing premiums.

The liability for future policy benefits is equal to the present value of expected future benefits and claim-related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain
in-force
from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), estimates of future
in-force
rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance products. The liability is measured for each group of contracts, or cohorts, using best estimate cash flow assumptions, which are reviewed at least annually in the fourth quarter or more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits, at the
locked-in
discount rate, resulting from cash flow assumption updates and variances between actual and expected experience is reflected as liability remeasurement (gains) losses in the consolidated statements of income.

See notes 2 and 10 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the liability for future policy benefits.

Long-term care insurance

Key cash flow assumptions used to estimate the liability for future policy benefits for our long-term care insurance products include claim termination rates, incidence and benefit utilization rates, mortality, lapse rates and
in-force
rate actions. Claim termination rates represent the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates represent how much of the available policy benefits are expected to be used.
In-force
rate actions represent the remaining premium rate increases and associated benefit reductions not yet achieved in our long-term care insurance multi-year
in-force
rate action plan and are based on our best estimate given our current plans for rate increase filings and our historical experience regarding rate increase approvals.
In-force
rate actions also include cash payments made to policyholders who elect certain reduced benefit options in connection with legal settlements, referred to as settlement payments.

114

Table of Contents

In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $61 million primarily related to updates to our healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
Updates also included favorable assumption updates for future
in-force
rate action approvals and benefit reductions based on recent favorable rate increase approval experience and feedback from regulators, along with the reflection of the third legal settlement, which had a muted favorable income statement impact in the fourth quarter of 2023 because it primarily impacted profitable uncapped cohorts. In the fourth quarter of 2022, liability remeasurement gains (losses) within net income included favorable cash flow assumption updates of $303 million reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, which primarily impacted capped cohorts.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202320222023 vs. 2022
Present value of expected net premiums (1)$15,333$16,691$(1,358)(8)%
Present value of expected future policy benefits (1)$50,095$50,551$(456)(1)%
Column 1Column 2
(1)At the locked-in discount rate.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
5% increase in future claim costs (1)$(1,490)
Reduction in claim termination rates (2)$(290)
10% reduction in benefit of future in-force rate actions (3)$(175)
Column 1Column 2
(1)Reflects the impact of an unfavorable assumption change for claim terminations, incidence or benefit utilization rates (any discrete adverse assumption changes therefrom or in combination with, that results in our future claim costs increasing by 5%).
Column 1Column 2
(2)Reflects the impact of a 3% decrease in mortality and 8% decrease in lapse rates.
Column 1Column 2
(3)Reflects the impact of an unfavorable change to our assumptions for future premium rate increases and benefit reductions.

Life insurance

Key cash flow assumptions used to estimate the liability for future policy benefits for our life insurance products include mortality and lapse rates.

In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $56 million primarily as a result of updates to our mortality assumptions, including emerging experience related to more modest mortality improvement and an expectation that mortality will continue at elevated levels in the near-term
post-COVID-19.
There were no cash flow assumption changes for our life insurance products in the fourth quarter of 2022.

115

Table of Contents

A summary of certain of our significant estimates used in the calculation of our life insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202320222023 vs. 2022
Present value of expected net premiums (1)$1,835$1,573$26217%
Present value of expected future policy benefits (1)$2,192$2,127$653%
Column 1Column 2
(1)At the locked-in discount rate and excluding the impacts of flooring adjustments. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
2% higher mortality$(20)
10% increase in lapses$(60)

Fixed annuities

The key cash flow assumption used to estimate the liability for future policy benefits for our fixed annuity products is mortality.

In the fourth quarters of 2023 and 2022, our annual review of cash flow assumptions had no impact on liability remeasurement gains (losses) within net income for our fixed annuity products.

A summary of certain of our significant estimates and assumptions used in the calculation of our fixed annuities liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202320222023 vs. 2022
Total present value of expected future policy benefits (1)$2,691$2,897$(206)(7)%
Column 1Column 2
(1)At the locked-in discount rate.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
10% lower mortality$(60)

Policyholder account balances – additional insurance liabilities

The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product

116

Table of Contents

features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims, commonly referred to as the additional insurance liability. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.

We perform an annual review of assumptions for our universal and term universal life insurance products in the fourth quarter. Our 2023 review resulted in an expense recorded to
pre-tax
income of $200 million primarily to reflect unfavorable persistency and mortality assumptions. We made unfavorable updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in universal and term universal life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
Our 2022 review resulted in a benefit recorded to
pre-tax
income of $37 million largely associated with higher interest rates.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
100 basis point decrease in projected crediting rates$(50)
10% increase in persistency$(213)
2% higher mortality$(42)

Liability for policy and contract claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss).

Mortgage insurance

Estimates and actuarial assumptions used for establishing loss reserves involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on Enact’s loss reserves and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. The sources of uncertainty affecting the estimates are numerous and include factors internal and external to Enact. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external influences include changes in home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on Enact’s reserves, results of operations and financial condition.

117

Table of Contents

Enact establishes reserves to recognize the estimated liability for losses and loss adjustment expenses related to defaults on insured mortgage loans. Loss reserves are established by estimating the number of loans in the inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase.

Enact’s management monitors actual experience, and where circumstances warrant, will revise its assumptions. The liability for loss reserves is reviewed regularly, with changes in estimates of future claims recorded through net income. Estimation of losses is based on historical claim and cure experience and covered exposures and is inherently judgmental. Future developments may result in losses greater or less than the liability for loss reserves provided.

Enact’s loss reserves were $518 million and $519 million as of December 31, 2023 and 2022, respectively. In considering the potential sensitivity of the factors underlying Enact’s best estimate of its mortgage insurance reserves, it is possible that even a relatively small change in the estimated claim or severity rate could have a significant impact on loss reserves and, correspondingly, on our results of operations. For example, based on Enact’s actual experience during the three-year period ended December 31, 2023, a quarterly change of 5% in its average claim rate would change the gross loss reserve amount for such quarter by $75 million and a change of 4% in its average severity rate would change the gross loss reserve amount for such quarter by $19 million.

Valuation of fixed maturity securities.

Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.

The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the

period-to-period

changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. Additionally, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investments portfolio.

Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2023, 6% of our total fixed maturity securities related to Level 3 fixed maturity securities valued using internal pricing models. See notes 2, 5 and 21 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.

118

Table of Contents

The following tables summarize the primary sources of data considered when determining the fair value of fixed maturity securities as of December 31:

2023
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$41,311$$41,311$
Broker quotes221221
Internal models5,2492,3742,875
Total fixed maturity securities$46,781$$43,685$3,096
2022
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$41,113$$41,113$
Broker quotes250250
Internal models5,2202,2802,940
Total fixed maturity securities$46,583$$43,393$3,190

Consolidated Balance Sheets

Total assets

. Total assets increased $1,103 million from $89,714 million as of December 31, 2022 to $90,817 million as of December 31, 2023.

Column 1Column 2Column 3Column 4
Invested assets increased $803 million primarily attributable to increases of $490 million in limited partnerships, $198 million in fixed maturity securities and $165 million in other invested assets, partially offset by a decrease of $208 million in commercial mortgage loans in 2023. Limited partnerships increased largely from capital calls in 2023. The increase in fixed maturity securities was predominantly related to tightening credit spreads increasing the fair value of our fixed maturity investment portfolio, partially offset by net sales and maturities in 2023. The increase in other invested assets was primarily related to derivatives and bank loan investments. Commercial mortgage loans decreased mostly due to payments outpacing originations in 2023. We continue to monitor macroeconomic trends and rebalance our investment holdings in commercial real estate.
Column 1Column 2Column 3Column 4
Cash and cash equivalents increased $416 million primarily related to net sales and maturities of fixed maturity securities and commercial mortgage loan payments outpacing originations, partially offset by net withdrawals from our investment contracts and repurchases of Genworth Financial’s common stock in 2023.
Column 1Column 2Column 3Column 4
Deferred acquisition costs decreased $223 million primarily attributable to amortization in our life and long-term care insurance products in 2023.

Total liabilities

. Total liabilities increased $1,154 million from $81,328 million as of December 31, 2022 to $82,482 million as of December 31, 2023.

Column 1Column 2Column 3Column 4
The liability for future policy benefits increased $2,248 million primarily from a decrease in the single-A interest rate used to discount the liability for future policy benefits and aging of our long-term care insurance in-force block, partially offset by the runoff of our life insurance and fixed annuity products. The increase also includes the effects of changes in cash flow assumptions and variances between actual and expected experience. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in cash flow assumptions.

119

Table of Contents

Column 1Column 2Column 3Column 4
Policyholder account balances decreased $1,024 million primarily from surrenders, benefit payments and policy charges in our fixed annuity and universal and term universal life insurance products in 2023, partially offset by an increase in additional insurance liabilities due to changes in cash flow assumptions. See “—Critical Accounting Estimates—Policyholder account balances —additional insurance liabilities” for additional information.
Column 1Column 2Column 3Column 4
Market risk benefit liabilities decreased $123 million mostly related to favorable equity market performance in 2023.

Total equity

. Total equity decreased $51 million from $8,386 million as of December 31, 2022 to $8,335 million as of December 31, 2023.

Column 1Column 2Column 3Column 4
We reported net income available to Genworth Financial, Inc.’s common stockholders of $76 million for the year ended December 31, 2023.
Column 1Column 2Column 3Column 4
Unrealized gains (losses) on investments increased total equity by $1,277 million primarily from tightening credit spreads in 2023.
Column 1Column 2Column 3Column 4
Change in the discount rate used to measure future policy benefits decreased total equity by $1,036 million largely attributable to a decrease in the single-A interest rate used to discount the liability for future policy benefits and related reinsurance recoverables (net of deferred taxes) in 2023.
Column 1Column 2Column 3Column 4
Treasury stock increased $299 million primarily due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other costs paid in connection with acquiring the shares, resulting in a decrease to total equity in 2023.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.

Overview of cash flows—Genworth and subsidiaries

The following table sets forth our condensed consolidated cash flows for the years ended December 31:

(Amounts in millions)202320222021
Net cash from operating activities$597$1,049$437
Net cash from investing activities1,261733896
Net cash used by financing activities(1,443)(1,554)(2,419)
Net increase (decrease) in cash before foreign exchange effect$415$228$(1,086)

Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits and claims paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions.

120

Table of Contents

2023 compared to 2022

Net cash inflows from operating activities were lower primarily due to higher benefit payments in our long-term care insurance business in 2023, partially offset by net cash disbursements in 2022 associated with the return of cash collateral received from counterparties under our derivative contracts.

Net cash inflows from investing activities were higher mainly due to commercial mortgage loan payments outpacing originations in 2023 compared to originations outpacing payments in 2022, as well as higher net sales and maturities of fixed maturity securities in 2023.

Net cash outflows used by financing activities were lower primarily due to lower repurchases and repayments of Genworth Holdings’ debt in 2023 and a settlement payment related to a Tax Matters Agreement with GE in 2022 that did not recur, partially offset by higher repurchases of Genworth Financial’s common stock in 2023.

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 18 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. As of December 31, 2023, our principal U.S. life insurance subsidiaries had negative unassigned surplus of approximately $563 million under statutory accounting, and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations. Insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.

Enact Holdings continues to evaluate its capital allocation strategy to consistently support its existing policyholders, grow its mortgage insurance business, fund attractive new business opportunities and return capital to shareholders. In addition to its quarterly cash dividend program, on November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the

121

Table of Contents

authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings in 2023, comprised of quarterly dividends, a special dividend and share repurchases. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Enact Holdings’ stock price and trading volume, and general business and market conditions, among other factors.

On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under its existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total of $295 million, excluding excise taxes and other associated costs. In 2024, Genworth Financial also repurchased 4,197,740 shares of its common stock through February 13, 2024 for approximately $25 million, leaving approximately $316 million remaining authorization under the share repurchase program. Further repurchases under the program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or by other means, including through Rule
10b5-1
trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

Our future use of liquidity and capital will prioritize future strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. We expect to continue to provide capital to CareScout to help advance our senior care growth initiatives related to the needs of elderly Americans, as well as their caregivers and families. We may also from time to time seek to repurchase or redeem outstanding debt (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise.

Genworth Holdings had $350 million and $307 million of unrestricted cash and cash equivalents as of December 31, 2023 and 2022, respectively. The increase was principally driven by capital returns from Enact Holdings and intercompany cash tax payments received from Genworth Holdings’ subsidiaries, partially offset by Genworth Financial’s common stock repurchases and debt interest payments in 2023. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months. However, in the third quarter of 2023, we made a federal tax payment based on our projection of current taxable income and utilization of our remaining foreign tax credits, and we expect the amount of intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2024 as compared to the amounts received during 2022 and 2023. We also expect Genworth Holdings’ liquidity to continue to be significantly impacted by the amounts and timing of Genworth Financial’s share repurchases as well as future dividends and other forms of capital returns from Enact Holdings.

We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market

122

Table of Contents

conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations,” and “Item 1A—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.” These risks may be exacerbated by the economic impact of current elevated interest rates and overall housing trends.

During 2023 and 2022, Genworth Holdings repurchased $32 million and $143 million, respectively, principal amount of its debt, and in 2022, early redeemed $152 million of its 4.80% senior notes originally scheduled to mature in February 2024. As of December 31, 2023, Genworth Holdings had $856 million principal of outstanding debt, with no maturities due until June 2034.

On October 25, 2023, Genworth Holdings completed a consent solicitation from bondholders representing a majority in principal amount of its 6.50% senior notes due in 2034 (“2034 Notes”) to amend the Replacement Capital Covenant, dated as of November 14, 2006. The amendment permits Genworth Holdings to repay, redeem or repurchase $2,000 principal amount of its floating rate junior subordinated notes due in 2066 (“2066 Notes”) for each $1,000 principal amount of its 2034 Notes repaid, redeemed or repurchased.

In December 2022, the Board of Governors of the Federal Reserve System adopted a final rule that established benchmark rates, based on the Secured Overnight Financing Rate (“SOFR”), that replaced the London Interbank Offered Rate (“LIBOR”) after its elimination on June 30, 2023. Pursuant to the final rule, Genworth Holdings’ 2066 Notes, which had an annual interest rate equal to three-month LIBOR plus 2.0025%, transitioned in the third quarter of 2023 to an annual interest rate equal to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. We do not expect this change to have a material impact on our results of operations or liquidity. In addition, given the reduction in Genworth Holdings’ debt and corresponding decrease in debt service costs, we do not expect a significant impact on our liquidity from the rise in interest rates in 2022 and 2023.

On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. As of December 31, 2023, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn. Enact Holdings also has $750 million principal amount of senior notes due in August 2025.

Enact Holdings continually evaluates opportunities based upon market conditions to further increase its financial flexibility including through raising additional capital, restructuring or refinancing some or all of its outstanding debt or pursuing other options such as reinsurance or credit risk transfer transactions. There can be no guarantee that any such opportunities will be available on favorable terms or at all.

Other than its senior notes due in August 2025, Enact Holdings has no material outstanding debt obligations that are expected to affect its liquidity over the next five years. We believe that the operating cash flows generated by Enact Holdings’ mortgage insurance subsidiaries will provide the funds necessary to satisfy its claim payments, operating expenses and taxes.

For further information about our borrowings, refer to note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Regulated insurance subsidiaries

Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 22 in our consolidated financial statements under “Item 8—Financial Statements

123

Table of Contents

and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. Based on estimated statutory results as of December 31, 2023, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $336 million in 2024 without affirmative regulatory approval. However, Enact Holdings may choose not to pay dividends in 2024 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements.

The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Given the challenging macroeconomic environment in 2022 and 2023, employee costs were higher driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these conditions persist for a long period of time, they could have a material adverse impact on our liquidity, results of operations and financial condition. We will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity.

Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. For long-duration coverage products, we generally anticipate a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form
10-K.
For information on discounted and undiscounted expected future benefit payments, see note 10 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Our projected payments are principally associated with our long-term care insurance products, for which we expect overall claim costs to continue to increase as the insured individuals in our two largest blocks approach their peak claim years, which are over a decade away. Actual claims on products that provide long-duration coverage typically emerge over many years, change over time and are difficult to accurately predict. Therefore, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of payments.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2023, our total cash, cash equivalents and invested assets were $62.0 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2023.

Guarantees and other
off-balance
sheet commitments

Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.

124

Table of Contents

Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies
in-force
prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2023, the risk
in-force
of active policies was approximately $893 million.

Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures.

Genworth Financial and certain of its holding company subsidiaries also provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $67 million and $69 million as of December 31, 2023 and 2022, respectively.

As of December 31, 2023, we were committed to fund $1,530 million in limited partnership investments, $117 million of bank loan investments, $42 million in private placement investments and $13 million in commercial mortgage loan investments.

Supplemental Condensed Consolidating Financial Information

As discussed above in “—Liquidity and Capital Resources,” Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933). Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial. Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in accordance with Rule
13-01
of Regulation
S-X,
we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities.

125

Table of Contents

Back to the GNW company profile or the MD&A index.